文献速递生殖医学产科

Podocalyxin抑制人胚胎体外着床并与IVF着床失败相关

Podocalyxin inhibits human embryo implantation in vitro and luminal podocalyxin in putative receptive endometrium is associated with implantation failure in fertility treatment.
PubMed 文献 · Fertil Steril · 2021-07-13

该研究探讨子宫内膜上皮podocalyxin(PCX)是否抑制人胚胎体外着床及IVF患者的着床。体外实验显示高PCX抑制囊胚附着和穿透;81例IVF患者中,LE的PCX阳性者临床妊娠率仅18%,阴性者为53%,PCX阳性与无临床妊娠的OR为4.95(95%CI 1.48-14.63)。结论:PCX抑制胚胎着床,评估PCX可能有助于评价和优化子宫内膜容受性。

要点

  • 高PCX抑制人囊胚体外附着和穿透
  • 81例IVF患者中LE的PCX阳性率27%,阴性率73%
  • PCX阳性者临床妊娠率18%,阴性者53%

核心结论

  • Podocalyxin抑制胚胎着床,评估PCX可能有助于评价和优化生育治疗中的子宫内膜容受性。

研究设计与样本

  • 体外研究:在高PCX的Ishikawa单层细胞模型中检测人囊胚附着和穿透。
  • 回顾性分析:81例接受冻融胚胎移植的IVF患者,在其后的自然周期取 putative receptive 子宫内膜组织,用免疫组化检测PCX,分析LE的PCX染色与临床妊娠(作为成功着床的代理指标)的关联。
  • 研究地点:澳大利亚RMIT大学和比利时布鲁塞尔自由大学。

主要发现

  • 高PCX的Ishikawa单层显著抑制囊胚附着和穿透。
  • 81例 putative receptive 组织中,73%为PCX阴性,27%为LE的PCX异质性阳性。
  • PCX阴性LE者临床妊娠率为53%,PCX阳性LE者仅18%。
  • LE的PCX阳性时,无临床妊娠的OR为4.95(95%CI 1.48-14.63)。

关键数值与推荐

  • 81例 putative receptive 子宫内膜组织中,LE的PCX阴性73%、异质性阳性27%。
  • PCX阴性LE者临床妊娠率53%,PCX阳性LE者18%。
  • LE的PCX阳性与无临床妊娠的OR为4.95(95%CI 1.48-14.63)。

临床怎么用

  • PCX可能作为评估子宫内膜容受性的候选标志物,用于生育治疗的评估和优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study whether endometrial epithelial podocalyxin (PCX) inhibits implantation of human embryos in vitro and in patients undergoing in vitro fertilization (IVF). DESIGN: We have recently identified PCX as a key negative regulator of endometrial epithelial receptivity. Podocalyxin is expressed in all epithelial cells in the nonreceptive endometrium, but is selectively downregulated in the luminal epithelium (LE) for receptivity. In the current study, we first investigated whether high levels of PCX in Ishikawa monolayer inhibit attachment and/or penetration of human blastocysts in in vitro models. We then examined PCX by immunohistochemistry in putative receptive endometrial tissues biopsied from 81 IVF patients who underwent frozen embryo transfer in the next natural cycle and retrospectively analyzed the association between PCX staining in LE and clinical pregnancy as a proxy of successful implantation. SETTING: RMIT University, Australia; Vrije Universiteit Brussel, Belgium. PATIENT(S): In vitro fertilization patients undergoing frozen/thawed embryo transfer. INTERVENTION(S): N/A. MAIN OUTCOME MEASURE(S): Endometrial epithelial PCX inhibits implantation of human embryos in vitro and in IVF patients. RESULT(S): High levels of PCX in Ishikawa monolayer significantly inhibited blastocyst attachment and penetration. Among the 81 putative receptive tissues, 73% were negative, but 27% were heterogeneously positive for PCX in LE. The clinical pregnancy rate was 53% in those with a PCX-negative LE but only 18% in those with a PCX-positive LE. If LE was positive for PCX, the odds ratio of no clinical pregnancy was 4.95 (95% Confidence interval, 1.48-14.63). CONCLUSION(S): Podocalyxin inhibits embryo implantation. Assessment of PCX may aid the evaluation and optimization of endometrial receptivity in fertility treatment.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Heng S, Samarajeewa N, Aberkane A, et al. Podocalyxin inhibits human embryo implantation in vitro and luminal podocalyxin in putative receptive endometrium is associated with implantation failure in fertility treatment. Fertil Steril. 2021. PMID: 34272065. doi:10.1016/j.fertnstert.2021.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。